BIO-B
Bio-Rad Laboratories, Inc. Class BShare classes & related securities
BIO-B is the same company as:
Recent alerts on BIO-B
All signals →
News
S&P 500 Shake-Up: New Entrants Driving Market Momentum
14d ago
News
Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories
15d ago
News
Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU
32d ago
News
Bio-Rad outlines 2026 currency-neutral revenue growth of -3% to +0.5% amid Middle East disruption
32d ago
News
Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements
109d ago
News
Qiagen Explores Possible Sale After New Buyer Talks: Report
132d ago
News
Antibody Optimization Service (Affinity Maturation, Humanization, Phage Display, AI-based Computational Optimization) Market Trends Analysis and Growth Forecast Report 2025-2033
132d ago
News
Custom Antibody Market to Reach USD 1,297.65 Million by 2033, Growing Demand for Precision Medicine and Targeted Therapies to Drive the Market – SNS Insider
133d ago
Get push alerts for BIO-B
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS